Study Conduct

23andMe to create therapeutics group, names Richard Scheller CSO

Thursday, March 12, 2015 01:03 PM

23andMe, a personal genetics company based in Mountain View, Calif., has created a new therapeutics group and has named Richard Scheller, Ph.D., to lead it as chief science officer and head of therapeutics. Scheller retired in December 2014 from a 14-year career at Genentech, where he was executive vice president of research and early development.

More... »


WMIS, National Cancer Institute to collaborate on expansion of co-clinical trials

Wednesday, March 11, 2015 12:29 PM

The World Molecular Imaging Society (WMIS) is collaborating with the National Cancer Institute (NCI), part of the NIH, to promote best practices for co-clinical trials to speed the discovery of more and better treatments for cancer and other diseases.

More... »


ERT-PHT combination would create largest provider of eCOA and ePRO, data analytics for clinical trials industry

Monday, March 9, 2015 08:00 AM

By Ronald Rosenberg
CenterWatch Staff Writer

The pending combination of eResearch Technology (ERT), a leader in patient-centric endpoint data collections, and PHT, a leading electronic diary solutions provider for clinical trials and developer of patient-driven mobile apps, would create the largest company for patient endpoint collection and data analytics in global clinical trials.

More... »

International site network Synexus eyes acquisitions of, partnerships with U.S. investigative sites in 2015

Monday, March 9, 2015 08:00 AM

By Ronald Rosenberg
CenterWatch Staff Writer

Combining a change in financial owner-ship with overseas expansion plans, Synexus, one of the largest international investigative site networks, has set its sights on acquiring or partnering with an undisclosed number of U.S. investigative sites this year.

More... »

Techorizon launches electronic tool for feasibility study performance

Thursday, March 5, 2015 12:31 PM

Techorizon, a technology company based in Verona, Italy, with North American offices in Cambridge, Mass., has launched FeRMI, an electronic application for the conduct of clinical trial feasibility studies. Techorizon also launched a new web site.

More... »

New patient contact registry for rare eosinophilic gastrointestinal diseases

Wednesday, March 4, 2015 09:01 AM

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) has launched a patient contact registry for individuals with eosinophilic gastrointestinal diseases (EGID), a group of rare diseases. The registry is located at www.rdcrn.org/CEGIR. Its purpose is to create a single, international database with information submitted by patients with EGID and their families. The database will enable CEGIR investigators to identify and recruit patients with EGID for new research studies for improving treatments and clinical care.

More... »

ERT to acquire PHT

Monday, March 2, 2015 03:38 PM

ERT, a global provider of patient safety and efficacy endpoint data collection, has signed a definitive agreement to acquire PHT, an electronic patient diary solutions provider that helps biopharmaceutical companies collect and manage clinical trial data.

More... »

Akili collaborates with Autism Speaks affiliate DELSIA

Monday, March 2, 2015 03:11 PM

Boston-based Akili Interactive Labs, developing clinically-validated video games for cognitive assessment and personalized treatment, has entered into a clinical collaboration agreement with Delivering Scientific Innovation for Autism (DELSIA).

More... »

Novo Nordisk, Takeda, Servier, Celgene among top sponsors rated by investigative sites in new CenterWatch survey

Monday, March 2, 2015 08:00 AM

More than 1,900 global investigative sites rate the best biopharmaceutical companies with which to work in a new survey conducted by CenterWatch, a leading provider of global clinical trials information. The survey results were released today in the March issue of The CenterWatch Monthly newsletter.

More... »

Patients’ increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Monday, March 2, 2015 08:00 AM

By Ronald Rosenberg
CenterWatch Staff Writer

Social media continues to play a major role in clinical trial patient recruitment and participation, according to former trial patients who still share information about their experiences with friends and others online—conversations that can influence whether prospective patients join a trial.

More... »

CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs